Neogen Chemicals Results 2026: FY25 and Q1FY26 numbers

Why Neogen Chemicals’ latest numbers matter

Neogen Chemicals (NSE: NEOGEN, BSE: 542665) has reported volatile quarterly profitability through FY25 and into FY26, even as its revenue base remains near the ₹180-₹220 crore per quarter range. The latest available quarterly dataset through Dec 2025 shows revenue rising to ₹222 crore, while interest costs increased sharply compared with earlier quarters. Separately, the company has disclosed a schedule for its next board meeting and results date, alongside an earnings conference call.

As of 15 May 2026 at 15:29, Neogen Chemicals share price is ₹1,664.80. The screen data also shows the stock at ₹1,664.8 with a move of -₹14.8 (0.9%) and a market capitalisation of ₹4,559 crore.

Stock snapshot and valuation metrics on screen

The same snapshot lists a Stock P/E of 130.9 and P/B of 4.7, with book value at ₹352.2 per share. Dividend yield is shown at 0.06%, and a final dividend of ₹1 per share is also listed with an ex-date in September 2025.

These valuation ratios matter because the quarterly profit profile in the provided financial tables is uneven, with EPS for some quarters dropping close to ₹1 per share in the latest trailing quarters shown.

Quarterly operating trend through Dec 2025

In the quarterly income statement (figures in ₹ crore), revenue moved from ₹203 crore in Dec 2024 to ₹222 crore in Dec 2025. Expenses increased broadly in step, keeping operating profit in a tight band, though margins compressed versus earlier peaks.

Operating profit margin is shown at 17% in Dec 2024, dipping to 11% in Mar 2025, and then stabilising in the 14-17% range through Sep 2025, before coming in at 15% in Dec 2025. EBITDA is shown at ₹36 crore in Dec 2024 and ₹34 crore in Dec 2025.

A notable shift in the cost line is interest. Interest stayed at ₹13 crore for multiple quarters but rose to ₹20 crore in Sep 2025 and ₹22 crore in Dec 2025, which weighed on profit before tax.

Profit before tax and net profit: pressure points

Profit before tax (PBT) in the quarterly statement fell to ₹4 crore in Mar 2025, recovered to ₹14 crore in Jun 2025, and then slipped to ₹5-₹6 crore in Sep-Dec 2025. Net profit is shown at ₹10 crore in Dec 2024, ₹2 crore in Mar 2025, ₹10 crore in Jun 2025, ₹3 crore in Sep 2025, and ₹4 crore in Dec 2025.

The quarterly EPS line in the same table tracks this softness, showing ₹4 in Dec 2024, ₹1 in Mar 2025, ₹4 in Jun 2025, and ₹1 in Sep and Dec 2025. Another provided dataset explicitly states adjusted EPS of 1.40 for the quarter ended Dec 2025.

FY25 audited performance: standalone vs consolidated

For FY25 (Apr 2024 to Mar 2025), the standalone results table in the provided filing shows revenue of ₹773.65 crore, other income of ₹9.76 crore, and total income (net) of ₹783.41 crore. Profit after tax for FY25 is listed as ₹48.41 crore on a standalone basis, with FY25 basic and diluted EPS at ₹18.35.

The consolidated FY25 table shows revenue from operations of ₹777.56 crore, other income of ₹4.01 crore, and total income (net) of ₹781.57 crore. Consolidated profit after tax for FY25 is shown at ₹34.83 crore, and consolidated FY25 EPS is shown at ₹13.20.

A separate market-data style summary also expresses FY25 revenue as ₹778 crore (converted from ₹7.78 billion) and the prior year as ₹691 crore (from ₹6.91 billion), stating a 12.58% increase.

Q1 FY26 performance and the Dahej plant disruption

For Q1 FY26 (quarter ended June 30, 2025), standalone revenue from operations is listed at ₹184.58 crore, with standalone profit after tax at ₹14.23 crore and EPS at ₹5.40 (not annualised). On a consolidated basis for Q1 FY26, revenue from operations is ₹186.73 crore, profit after tax is ₹10.26 crore, and EPS is ₹3.89 (not annualised).

Management commentary in the provided text attributes Q1 FY26 resilience to a diversified business model, even as the Dahej plant was unavailable for the entire quarter due to a fire. The company also noted that Neogen Ionics began contributing by initiating commercial sales in both electrolyte and lithium electrolyte salts.

Exceptional items linked to the fire: where it appears

In the quarterly results table (figures in ₹ crore), “Exceptional Income / Expenses” shows -₹14 crore in Mar 2025 and zero in the other listed quarters through Dec 2025. Another detailed results summary states exceptional items in Q4 FY25 and FY25 relate to “fire loss net of insurance claim” amounting to ₹13.56 crore (standalone) and ₹14.08 crore (consolidated).

These entries help explain why Q4 FY25 standalone EPS is listed at ₹1.97 while FY25 EPS is much higher at ₹18.35.

Corporate actions and upcoming dates investors track

The corporate actions table lists multiple “Stock Result” ex-dates and one dividend ex-date. It also flags a board meeting scheduled on 16/05/2026.

The text also mentions an intimation of an earnings conference call scheduled for Monday, May 18, 2026 at 4, alongside references to earlier transcripts and investor presentations.

Key numbers at a glance

Market moves mentioned around results

Two price-reaction snippets are included in the provided text. One notes the stock slipped over 3% in morning trade on August 4 after Q1 FY26 results, with the stock opening at ₹1,539.80. Another notes the shares surged 3% following Q3 results, with the stock trading at ₹2,058.00 at 9:57 AM.

A separate line also shows a stock price of ₹1,565.2 on Sep 12, 2025 at 03:29 PM, with a move of -₹27.6 (-1.73%).

What to watch next

With the board meeting scheduled on 16 May 2026 for results, and an earnings conference call scheduled for 18 May 2026, the next formal update is likely to add clarity on margins, interest costs, and the pace of commercial traction in Neogen Ionics. For investors tracking the name, the combination of high on-screen P/E (130.9), rising interest costs in late-2025 quarters, and uneven quarterly EPS makes the upcoming disclosures especially important.